Lanzhou University Second Hospital, Lanzhou, China.
The Sixth Affiliated Hospital of Sun Yat-sen University, Guangzhou, China.
Surg Innov. 2020 Jun;27(3):291-298. doi: 10.1177/1553350620907812. Epub 2020 Feb 26.
A substantial proportion of patients undergoing colorectal surgery receive a temporary stoma, and the timing for stoma closure remains unclear. The aim of this study was to evaluate the safety and feasibility of early stoma closure (ESC) compared with routine stoma closure (RSC) after colorectal surgery. We comprehensively searched PubMed, Embase, and the Cochrane Library for randomized controlled trials that compared ESC and RSC after colorectal surgery. A total of 7 randomized controlled trials with 814 enrolled patients were identified for this meta-analysis. There were no significant differences between the ESC and RSC groups regarding the complications of stoma closure (26.8% and 16.6%, respectively; odds ratio [OR]: 1.30; 95% confidence interval [CI]: 0.89-1.90; = .17). A subgroup analysis was conducted by Clavien-Dindo grade of complication, and no significant difference was observed in any subgroup ( > .05). However, the ESC group had a significantly higher risk of wound complications than the RSC group (17.6% and 7.8%, respectively; OR: 2.61; 95% CI: 1.43-4.76; = .002), and the RSC group had more cases of small bowel obstruction than the ESC group (3.1% and 8.4%, respectively; OR: 0.37; 95% CI: 0.15-0.87; = .02). ESC is a safe and effective therapeutic approach in patients who have undergone colorectal surgery; it is associated with a reduced risk of bowel obstruction but a higher risk of wound complications.
相当一部分接受结直肠手术的患者需要接受临时造口术,而造口关闭的时机仍不清楚。本研究旨在评估结直肠手术后早期造口关闭(ESC)与常规造口关闭(RSC)的安全性和可行性。
我们全面检索了 PubMed、Embase 和 Cochrane 图书馆中比较结直肠手术后 ESC 和 RSC 的随机对照试验。共有 7 项随机对照试验,共纳入 814 名患者纳入本荟萃分析。ESC 组和 RSC 组在造口关闭并发症方面无显著差异(分别为 26.8%和 16.6%;优势比[OR]:1.30;95%置信区间[CI]:0.89-1.90; =.17)。根据 Clavien-Dindo 并发症分级进行亚组分析,未观察到任何亚组存在显著差异( >.05)。然而,ESC 组的伤口并发症风险显著高于 RSC 组(分别为 17.6%和 7.8%;OR:2.61;95%CI:1.43-4.76; =.002),RSC 组的小肠梗阻病例多于 ESC 组(分别为 3.1%和 8.4%;OR:0.37;95%CI:0.15-0.87; =.02)。
ESC 是接受结直肠手术患者的一种安全有效的治疗方法;它与降低肠梗阻风险相关,但与增加伤口并发症风险相关。